オーストラリアの糖尿病市場は2020年から2024年にかけて力強い成長を遂げ、年平均成長率（CAGR）11.3%を達成しました。この上昇傾向は今後も続くと予想され、2025年から2029年にかけては年平均成長率（CAGR）8.9%で成長すると予測されています。2029年末までに、糖尿病市場は2024年の27億3,680万米ドルから約46億9,190万米ドルに拡大すると予測されています。
オーストラリアの糖尿病装置および治療薬市場は、CGMの普及拡大、デジタルヘルスプラットフォームの統合、コネクテッド治療システムの進歩、そして規制枠組みの進化によって再編されつつあります。これらのトレンドは今後2〜4年でさらに加速し、患者モニタリングの効率化、治療調整の精度向上、そして市場全体の拡大につながると予想されます。
オーストラリアの糖尿病機器・治療市場は、確立された多国籍企業と新興の地元イノベーターがダイナミックに融合した市場です。近年の戦略的提携、合併、買収により競争環境は大きく変化しており、デジタル統合と規制の整合性がますます重視されています。今後数年間は、競争の激化と戦略的な統合により、オーストラリア全土でイノベーションが促進され、患者管理が強化されると予想されます。
オーストラリア市場には、糖尿病ケア分野における多国籍企業と新興の地元イノベーターが混在しています。体系化された医療制度と明確な償還経路は、市場の安定性を高め、市場参入を容易にしま。
本レポートは、オーストラリアの糖尿病業界に関する詳細なデータ中心の分析を提供し、診断・モニタリング機器、治療薬、領域など、幅広い分野にわたる市場機会と分析を網羅しています。国レベルで50以上のKPIを網羅した本レポートは、糖尿病市場のダイナミクス、市場規模と予測、そして市場シェア統計に関する包括的な理解を提供します。
BioIntel360の調査手法は、業界のベストプラクティスに基づいています。独自の分析プラットフォームを活用した公平な分析により、新興ビジネスおよび投資市場の機会に関する詳細な見解を提供します。
本レポートは、2020年から2029年にかけてのオーストラリアの糖尿病関連機器および治療薬市場について、データに基づいた詳細な分析を提供しています。主要な市場セグメントの概要は以下のとおりです。
目次
Table of Contents
1 Australia Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
2 Australia Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
2.1 Australia Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
2.2 Australia Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
3 Australia Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
4 Australia Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
5 Australia Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
6 Australia Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
7 Australia Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
8 Australia Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
9 Australia Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
10 Australia Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
11 Australia Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
11.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
12 Australia Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
13 Australia Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
14 Australia Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
List of Tables
Table 1: Australia Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: Australia Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: Australia Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: Australia Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: Australia Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: Australia Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: Australia Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: Australia Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: Australia Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: Australia Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: Australia Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: Australia Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: Australia Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: Australia Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: Australia Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: Australia Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: Australia Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: Australia Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: Australia Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: Australia Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: Australia Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: Australia Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: Australia Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: Australia Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: Australia Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: Australia Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: Australia Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: Australia Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: Australia Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: Australia Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: Australia Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: Australia Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: Australia Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: Australia Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: Australia Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: Australia Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: Australia Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: Australia Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: Australia Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: Australia Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
List of Figures
Figure 1: Australia Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: Australia Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: Australia Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: Australia Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: Australia Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: Australia Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: Australia Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: Australia Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: Australia Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: Australia Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: Australia Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: Australia Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: Australia Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: Australia Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: Australia Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: Australia Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: Australia Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: Australia Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: Australia Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: Australia Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: Australia Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: Australia Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: Australia Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: Australia Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: Australia Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: Australia Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: Australia Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: Australia Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: Australia Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: Australia Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: Australia Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: Australia Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: Australia Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: Australia Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: Australia Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: Australia Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: Australia Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: Australia Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: Australia Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: Australia Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: Australia Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: Australia Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: Australia Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: Australia Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: Australia Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: Australia Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: Australia Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: Australia Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: Australia Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: Australia Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: Australia Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: Australia Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: Australia Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
